Arthrosi Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Arthrosi therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Arthrosi Therapeutics Today - Breaking & Trending Today

URAT1 Inhibitor Beats Allopurinol for Treating Gout Arthritis With Tophi

AR882 is a novel and selective URAT1 inhibitor currently in clinical stage development for the treatment of gout with tophi. ....

Energy Computer Tomography , American College Of Rheumatology , American College , Robert Keenan , Arthrosi Therapeutics , Dual Energy Computer Tomography ,

URAT1 Inhibitor Beats Allopurinol for Treating Gout Arthritis With Tophi

The investigational drug AR882 appeared more effective and safer than allopurinol monotherapy in a phase 2 trial. AR882 is a novel and selective URAT1 inhibitor currently in clinical stage development for the treatment of gout with tophi. ....

Energy Computer Tomography , Energy Computed Tomography , American College Of Rheumatology , American College , Robert Keenan , Arthrosi Therapeutics , Dual Energy Computer Tomography , Dual Energy Computed Tomography ,

Sustained Serum Urate Reduction for Gout Patients Observed with AR882

In this data shown at ACR 2023, the URAT1 inhibitor known as AR882 showed promising phase 2b data for patients with gout.
....

San Diego , United States , Robertt Keenan , Energy Computer Tomography , American College Of Rheumatology Convergence , Trial Using Dual Energy Computed Tomography , American College Of Rheumatology , American College , Dual Energy Computer Tomography , Arthrosi Therapeutics , Chronic Gouty Arthritis , Subcutaneous Tophi , Proof Of Concept Trial Using Dual Energy Computed , Rheumatology Convergence ,

Novel Gout Drug Aces Mid-Stage Tests

Mechanism different from currently available therapies ....

San Diego , United States , Robert Keenan , John Gever , American College Of Rheumatology , Arthrosi Therapeutics , American College , Managing Editor ,

Arthrosi to Present Positive Phase 2 Data for its Novel Selective URAT1 Inhibitor AR882 in Patients with Tophaceous Gout at ACR Convergence 2023

/PRNewswire/ Arthrosi Therapeutics, Inc., a clinical-stage biotechnology company developing treatments for gout that dissolve uric acid crystals and prevent. ....

San Diego , United States , Alex Lobo , Litain Yeh , Shunqi Yan , European Alliance Of Associations , Trial Using Dual Energy Computed Tomography , Arthrosi Therapeutics Inc , Energy Computed Tomography , American College Of Rheumatology , Stern Investor Relations Inc , Robert Keenan , Chief Medical Officer , Dual Energy Computed Tomography , Chief Executive Officer Litain Yeh , Chronic Gouty Arthritis , Subcutaneous Tophi , Proof Of Concept Trial Using Dual Energy Computed , American College , European Alliance , Selective Uric Acid Transporter , Gout Patients , Various Baseline Characteristics Following , Week Treatment , Crystal Arthropathies , Clinical Science Poster ,